BRPI0504441A - vetores de expressão plasmidial contendo regiões especìficas para a expressão de proteìnas ou epìtopos recombinantes de rotavìrus e astrovìrus, processo de produção dos insumos para geração de imunobiológicos para diagnóstico - Google Patents

vetores de expressão plasmidial contendo regiões especìficas para a expressão de proteìnas ou epìtopos recombinantes de rotavìrus e astrovìrus, processo de produção dos insumos para geração de imunobiológicos para diagnóstico

Info

Publication number
BRPI0504441A
BRPI0504441A BRPI0504441-3A BRPI0504441A BRPI0504441A BR PI0504441 A BRPI0504441 A BR PI0504441A BR PI0504441 A BRPI0504441 A BR PI0504441A BR PI0504441 A BRPI0504441 A BR PI0504441A
Authority
BR
Brazil
Prior art keywords
immunobiologicals
epitopes
diagnosis
inputs
generation
Prior art date
Application number
BRPI0504441-3A
Other languages
English (en)
Inventor
Ana Carolina Magalhaes An Goes
Jose Paulo Gagliardi Leite
Marcia Terezinha Baroni Souza
Irene Trigueiros Araujo
Jean Claude D Halluin
Jose Godinho Da Junior Silva
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Priority to BRPI0504441-3A priority Critical patent/BRPI0504441A/pt
Priority to PCT/BR2006/000222 priority patent/WO2007045062A2/en
Priority to EP06804584A priority patent/EP2102344A4/en
Priority to US12/083,910 priority patent/US20100047763A1/en
Publication of BRPI0504441A publication Critical patent/BRPI0504441A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/12011—Astroviridae
    • C12N2770/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/14—Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

vetores de expressão plasmidial contendo regiões específicas para expressão de proteinas ou epítopos recombinantes de rotavirus e astrovirus, Processo de produção dos insumos para geração de imunobiológicos para diagnósticos. A presente invenção se refere à produção de proteínas virais específicas recombinantes, para aplicação na construção de um Kit de diagnóstico para detecção simultânea das duas principais virose gastroentéricas. Mais particularmente, as viroses detectadas pelo dito Kit são as causadas por retavírus e astrovírus.
BRPI0504441-3A 2005-10-20 2005-10-20 vetores de expressão plasmidial contendo regiões especìficas para a expressão de proteìnas ou epìtopos recombinantes de rotavìrus e astrovìrus, processo de produção dos insumos para geração de imunobiológicos para diagnóstico BRPI0504441A (pt)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BRPI0504441-3A BRPI0504441A (pt) 2005-10-20 2005-10-20 vetores de expressão plasmidial contendo regiões especìficas para a expressão de proteìnas ou epìtopos recombinantes de rotavìrus e astrovìrus, processo de produção dos insumos para geração de imunobiológicos para diagnóstico
PCT/BR2006/000222 WO2007045062A2 (en) 2005-10-20 2006-10-20 Plasmid expression vectors for expression of recombinant rotavirus and astrovirus proteins or epitopes.
EP06804584A EP2102344A4 (en) 2005-10-20 2006-10-20 PLASMID EXPRESSION VECTORS FOR THE EXPRESSION OF RECOMBINANT ROTAVIRUS AND ASTROVIRUS PROTEINS OR PEPPTHS AND THE PRODUCTION PROCESS OF RAW MATERIAL
US12/083,910 US20100047763A1 (en) 2005-10-20 2006-10-20 Plasmid Expression Vectors for Expression of Recombinant Rotavirus and Astrovirus Proteins or Epitopes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0504441-3A BRPI0504441A (pt) 2005-10-20 2005-10-20 vetores de expressão plasmidial contendo regiões especìficas para a expressão de proteìnas ou epìtopos recombinantes de rotavìrus e astrovìrus, processo de produção dos insumos para geração de imunobiológicos para diagnóstico

Publications (1)

Publication Number Publication Date
BRPI0504441A true BRPI0504441A (pt) 2007-06-26

Family

ID=37962862

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0504441-3A BRPI0504441A (pt) 2005-10-20 2005-10-20 vetores de expressão plasmidial contendo regiões especìficas para a expressão de proteìnas ou epìtopos recombinantes de rotavìrus e astrovìrus, processo de produção dos insumos para geração de imunobiológicos para diagnóstico

Country Status (4)

Country Link
US (1) US20100047763A1 (pt)
EP (1) EP2102344A4 (pt)
BR (1) BRPI0504441A (pt)
WO (1) WO2007045062A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2814508T (pt) * 2012-02-14 2017-07-19 Merial Inc Vacinas de subunidades de rotavírus e métodos para as produzir e uso das mesmas
CN108169492B (zh) * 2017-12-15 2019-12-17 东北农业大学 一种用于检测牛轮状病毒的胶体金免疫层析试纸条及其制备方法和应用
CN114814214A (zh) * 2022-06-28 2022-07-29 山东康华生物医疗科技股份有限公司 一种胶体金、乳胶微球标记联合的星状病毒免疫层析检测试剂盒及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5186933A (en) * 1986-12-30 1993-02-16 Baylor College Of Medicine Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system
US5625049A (en) * 1993-05-12 1997-04-29 Us Health Nucleic acids encoding human astrovirus serotype 2
WO2001059070A1 (en) * 2000-02-12 2001-08-16 Kim Won Yong Production method of recombinant rotavirus structural proteins and vaccine composition
WO2003014397A1 (en) * 2001-08-09 2003-02-20 Biomedlab Corporation Probe for detection of enteric virus detection kit and method for enteric virus with the same

Also Published As

Publication number Publication date
WO2007045062A8 (en) 2007-08-30
WO2007045062A2 (en) 2007-04-26
EP2102344A2 (en) 2009-09-23
US20100047763A1 (en) 2010-02-25
EP2102344A4 (en) 2012-02-22
WO2007045062A3 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
BR112013018704A2 (pt) corpo flutuante anular, e, processo de extinção pelo menos parcial de um movimento de balouço de um corpo flutuante na água
BR112014012275A2 (pt) purificação de proteína com a utilização de tampão bis-tris
BR112016020688A2 (pt) Composições úteis no tratamento da deficiência da ornitina transcarbamilase (otc)
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
BR112013032630A2 (pt) polipeptídeo heterodimerizado
EA201590545A1 (ru) Полипептиды, содержащие fc с измененным гликозилированием и сниженной эффекторной функцией
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
BR112015013525A2 (pt) método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão
BRPI0821034A8 (pt) Vírus influenza b recombinante, seu uso, metodo de preparação, composição de vacina o contendo e seu gene m, bem como ácido nucléico isolado, molécula do vírus influenza m e seu uso e método para aumentar a taxa de crescimento de vírus influenza b deficiente de replicação
ATE460473T1 (de) Immortalisierte entezelllinien zur viruserzeugung
WO2006060314A3 (en) Generation of replication competent viruses for therapeutic use
BR112013017815A2 (pt) módulo sublaminado, estrutura de compósito laminado e método para fabricar os mesmos
FI3581650T3 (fi) IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi
BR112013023006A8 (pt) formulações de suspensões não aquosas de anticorpos de alta concentração e viscosidade reduzida
BRPI0614761A2 (pt) proteìnas de fusão de albumina
BR112015018474A2 (pt) borracha natural modificada, processo para produzir a mesma, composição de borracha para pneu e pneumático
MX2012001882A (es) Anticuerpos contra el virus sincitial respiratorio (rsv) humano y metodos de uso.
BR112014015851A2 (pt) proteínas de ligação específicas duplas direcionadas contra il-13 e/ou il-17
JP2008515616A5 (pt)
BR112012009745A8 (pt) Membrana de troca catiônica, método para produzir a mesma, e vaso de eletrólise
MX2017008410A (es) Reduccion selectiva de residuos cisteina en anticuerpos il-17.
EA201491155A1 (ru) Новые мутантные про-нрф и их применение для получения бета-нрф
ES2627330T3 (es) Uso de JAZ5a para mejorar la resistencia a la sequía en una planta
BRPI1007118A2 (pt) artigo absorvente
PE20081687A1 (es) Proteina de fusion

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.